{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:14:47Z","timestamp":1792653287814,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008257","name":"Tarbiat Modares University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008257","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.intimp.2013.07.016","type":"journal-article","created":{"date-parts":[[2013,8,21]],"date-time":"2013-08-21T06:45:15Z","timestamp":1377067515000},"page":"608-616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE)"],"prefix":"10.1016","volume":"17","author":[{"given":"Forouzan","family":"Yousefi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massoumeh","family":"Ebtekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Soudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mahmoud","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2013.07.016_bb0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410310317","article-title":"Revised estimate of the prevalence of multiple sclerosis in the United States","volume":"31","author":"Anderson","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.intimp.2013.07.016_bb0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0361-9230(03)00095-9","article-title":"Neuropathology of multiple sclerosis\u2014new concepts","volume":"61","author":"Kornek","year":"2003","journal-title":"Brain Res Bull"},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2013.07.016_bb0015","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0022-510X(09)70003-6","article-title":"The history of multiple sclerosis: the changing frame of the disease over the centuries","volume":"277","author":"Murray","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.intimp.2013.07.016_bb0020","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/nn.3168","article-title":"Animal models of multiple sclerosis: the good, the bad and the bottom line","volume":"15","author":"Ransohoff","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.intimp.2013.07.016_bb0025","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.mvr.2009.02.001","article-title":"Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy","volume":"77","author":"Furlani","year":"2009","journal-title":"Microvasc Res"},{"issue":"Suppl. 6","key":"10.1016\/j.intimp.2013.07.016_bb0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00415-008-6003-0","article-title":"Animal models of multiple sclerosis for the development and validation of novel therapies \u2014 potential and limitations","volume":"255","author":"Mix","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.intimp.2013.07.016_bb0035","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneuroim.2010.12.004","article-title":"Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2","volume":"233","author":"Matysiak","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.intimp.2013.07.016_bb0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.autrev.2011.08.012","article-title":"Induction of antigen-specific tolerance through hematopoietic stem cell-mediated gene therapy: the future for therapy of autoimmune disease?","volume":"12","author":"Coleman","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.intimp.2013.07.016_bb0045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ana.22487","article-title":"Stem cell technology for neurodegenerative diseases","volume":"70","author":"Lunn","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.intimp.2013.07.016_bb0050","series-title":"Stem cells and neurodegenerative disease: cool science and scepticism","author":"Baker","year":"2009"},{"key":"10.1016\/j.intimp.2013.07.016_bb0055","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nature01552","article-title":"Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis","volume":"422","author":"Pluchino","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2013.07.016_bb0060","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nature03889","article-title":"Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism","volume":"436","author":"Pluchino","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2013.07.016_bb0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3727\/000000007783464678","article-title":"Neural stem cells, neural progenitors, and neurotrophic factors","volume":"16","author":"Hsu","year":"2007","journal-title":"Cell Transplant"},{"key":"10.1016\/j.intimp.2013.07.016_bb0070","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1634\/stemcells.2007-0073","article-title":"Clonal analysis of human embryonic stem cell differentiation into teratomas","volume":"25","author":"Blum","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.intimp.2013.07.016_bb0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0065-230X(08)00005-5","article-title":"The tumorigenicity of human embryonic stem cells","volume":"100","author":"Blum","year":"2008","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.intimp.2013.07.016_bb0080","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.scr.2009.02.002","article-title":"Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies","volume":"2","author":"Hentze","year":"2009","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.intimp.2013.07.016_bb0085","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1006\/mthe.2001.0327","article-title":"Human mesenchymal stem cells maintain transgene expression during expansion and differentiation","volume":"3","author":"Lee","year":"2001","journal-title":"Mol Ther"},{"key":"10.1016\/j.intimp.2013.07.016_bb0090","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2002-07-2104","article-title":"Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide","volume":"101","author":"Krampera","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2013.07.016_bb0095","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1182\/blood-2003-03-0877","article-title":"Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores","volume":"102","author":"Burt","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2013.07.016_bb0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nbt922","article-title":"Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells","volume":"22","author":"Draper","year":"2004","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.intimp.2013.07.016_bb0105","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/eji.200425405","article-title":"Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway","volume":"35","author":"Augello","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2013.07.016_bb0110","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/1352458506071301","article-title":"Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database","volume":"12","author":"Saccardi","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.intimp.2013.07.016_bb0115","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1474-4422(11)70121-1","article-title":"Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases","volume":"10","author":"Uccelli","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.intimp.2013.07.016_bb0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11481-009-9188-9","article-title":"Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis","volume":"5","author":"El-behi","year":"2010","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.intimp.2013.07.016_bb0125","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.coi.2010.10.012","article-title":"Why should mesenchymal stem cells (MSCs) cure autoimmune diseases?","volume":"22","author":"Uccelli","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.intimp.2013.07.016_bb0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/scrt94","article-title":"The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms","volume":"3","author":"Morando","year":"2012","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.intimp.2013.07.016_bb0135","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1111\/j.1582-4934.2010.01151.x","article-title":"Evolving paradigms for repair of tissues by adult stem\/progenitor cells (MSCs)","volume":"14","author":"Prockop","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.intimp.2013.07.016_bb0140","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.exphem.2012.05.006","article-title":"Mesenchymal stem cells inhibit Th17 cell differentiation by IL-10 secretion","volume":"40","author":"Qu","year":"2012","journal-title":"Exp Hematol"},{"key":"10.1016\/j.intimp.2013.07.016_bb0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.imlet.2012.10.010","article-title":"In vitro assessment of mesenchymal stem cells immunosuppressive potential in multiple sclerosis patients","volume":"149","author":"Zafranskaya","year":"2013","journal-title":"Immunol Lett"},{"key":"10.1016\/j.intimp.2013.07.016_bb0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ymeth.2008.03.006","article-title":"Adipose-derived stem cells: isolation, expansion and differentiation","volume":"45","author":"Bunnell","year":"2008","journal-title":"Methods"},{"key":"10.1016\/j.intimp.2013.07.016_bb0155","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/stem.629","article-title":"Concise review: adipose-derived stromal vascular fraction cells and stem cells: let's not get lost in translation","volume":"29","author":"Gimble","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.intimp.2013.07.016_bb0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2004.11.036","article-title":"Erythropoietin treatment improves neurological functional recovery in EAE mice","volume":"1034","author":"Zhang","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.intimp.2013.07.016_bb0165","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.4049\/jimmunol.1100530","article-title":"Segregated regulatory CD39+CD4+ T cell function: TGF-beta-producing Foxp3- and IL-10-producing Foxp3+ cells are interdependent for protection against collagen-induced arthritis","volume":"187","author":"Kochetkova","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.07.016_bb0170","doi-asserted-by":"crossref","first-page":"345806","DOI":"10.4061\/2010\/345806","article-title":"Fate of bone marrow-derived stromal cells after intraperitoneal infusion or implantation into femoral bone defects in the host animal","volume":"2010","author":"Wilson","year":"2010","journal-title":"J Tissue Eng"},{"key":"10.1016\/j.intimp.2013.07.016_bb0175","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3727\/096368912X657620","article-title":"Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination","volume":"22","author":"Payne","year":"2013","journal-title":"Cell Transplant"},{"key":"10.1016\/j.intimp.2013.07.016_bb0180","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/jcb.24437","article-title":"Comparative immunomodulatory properties of adipose-derived mesenchymal stem cells conditioned media from BALB\/c, C57BL\/6, and DBA mouse strains","volume":"114","author":"Hashemi","year":"2013","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.intimp.2013.07.016_bb0185","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0171-2985(86)80066-3","article-title":"Stimulation of human lymphocytes by phytohemagglutinin (PHA) in a new ultra-microtest plate","volume":"171","author":"Ocklind","year":"1986","journal-title":"Immunobiology"},{"key":"10.1016\/j.intimp.2013.07.016_bb0190","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","article-title":"Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy","volume":"106","author":"Zappia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2013.07.016_bb0195","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1002\/stem.194","article-title":"Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis","volume":"27","author":"Constantin","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.intimp.2013.07.016_bb0200","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.CIR.0000084828.50310.6A","article-title":"Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution","volume":"108","author":"Barbash","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2013.07.016_bb0205","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.intimp.2013.07.016_bb0210","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.4049\/jimmunol.162.4.2347","article-title":"Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways","volume":"162","author":"Laan","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.07.016_bb0215","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.4049\/jimmunol.0803962","article-title":"Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner","volume":"182","author":"Rafei","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.07.016_bb0220","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1093\/brain\/awp289","article-title":"Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis","volume":"132","author":"Brucklacher-Waldert","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2013.07.016_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2007.11.016","article-title":"Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease","volume":"193","author":"O'Connor","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.intimp.2013.07.016_bb0230","doi-asserted-by":"crossref","first-page":"e45675","DOI":"10.1371\/journal.pone.0045675","article-title":"The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2013.07.016_bb0235","first-page":"30","article-title":"Immunoregulatory role of mesenchymal stem cells in bone reparation processes","volume":"54","author":"Zubov","year":"2008","journal-title":"Fiziol Zh"},{"key":"10.1016\/j.intimp.2013.07.016_bb0240","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","article-title":"Immunomodulatory properties of mesenchymal stromal cells","volume":"110","author":"Nauta","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2013.07.016_bb0245","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/jcb.20904","article-title":"Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue","volume":"99","author":"Izadpanah","year":"2006","journal-title":"J Cell Biochem"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913003019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913003019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T23:00:20Z","timestamp":1715900420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576913003019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1567576913003019"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2013.07.016","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE)","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2013.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}